As of 30 Sep 2025, 72 institutional investors reported holding $1,082,598,160 in principal (par value) of DEXCOM INC - NOTE 0.375% 5/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $11,755,000 | $11,429,256 | -$2,330,820 | 91.57% | 5 |
| 2025 Q3 | $1,082,598,160 | $990,122,831 | +$25,447,746 | 91.18% | 72 |
| 2025 Q2 | $1,075,961,700 | $1,010,933,195 | -$21,454,839 | 93.9% | 70 |
| 2025 Q1 | $1,095,041,700 | $980,742,890 | -$5,907,151 | 89.25% | 69 |
| 2024 Q4 | $1,096,116,100 | $988,248,631 | +$4,222,146 | 89.78% | 68 |
| 2024 Q3 | $1,080,140,460 | $960,334,101 | +$65,589,769 | 88.52% | 66 |
| 2024 Q2 | $1,016,495,880 | $1,001,668,069 | +$1,001,669,722 | 97.84% | 62 |